Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Dehydrogenative Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed cross-dehydrogenative coupling for dienes. Efficient route for pharma intermediates with mild conditions and high yields.
Green synthesis of 2-acylamino alkyl thiazoles via visible light. Cost-effective, mild conditions, high purity for API intermediates and supply chain optimization.
Discover the novel AgOTf-catalyzed synthesis of allyl thiomethyl ethers from olefins and DMSO. A cost-effective, high-yield route for pharmaceutical intermediates.
Patent CN115894364A reveals a green water-based photocatalytic route for alkynyl tetrahydroisoquinoline derivatives, offering significant supply chain and cost advantages.
Patent CN111269228A reveals a green photocatalytic route for fluorescent indolizine derivatives, offering cost-effective manufacturing for pharma intermediates.
Patent CN109651344A reveals a green CuBr-catalyzed method for triarylmethane compounds, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Novel photocatalyst-free method for high-purity homoallylamine intermediates using water and visible light, ensuring cost-effective and scalable manufacturing.
Patent CN115536605A details Ir-catalyzed oxazole synthesis. Offers cost-effective routes for COX-2 inhibitors. Reliable pharma intermediate supplier.
Patent CN106316920B reveals a copper-catalyzed cross-dehydrogenative coupling route for indole glycine derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN112028873A reveals a room-temperature route for N-(2-quinoline)-2-ketones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111423405A details a novel Pd-catalyzed cross-dehydrogenative coupling route for benzopyran-3-ol derivatives, offering high yield and mild conditions for pharmaceutical intermediates.
Patent CN111606894A reveals mild Ag-catalyzed C-H activation for ether alpha-position, offering cost-effective routes for drug synthesis.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN117210828B enables metal-free electrochemical thioglycoside synthesis. Offers high purity, reduced costs, and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN109651344B reveals a copper-catalyzed green route for triarylmethanes. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free synthesis of methylthiomethyl esters using DMSO. Cost-effective, scalable pharmaceutical intermediate manufacturing with high purity standards.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.